SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
批准号:
3249976
负责人:
AUGUST H MAKI
金额:
$12.68万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-01-01 至 1993-09-29
关键词:
DNA DNA binding protein Escherichia coli RNA Rauscher's virus bacterial proteins bacterial virus binding proteins chemical binding chemical structure function fluorescence heavy metals intermolecular interaction metal complex microwave spectrometry molecular biology molecular energy level molecular stacking mutant nuclear magnetic resonance spectroscopy oligonucleotides phosphorescence point mutation polymers polynucleotides protein sequence site directed mutagenesis triplet state tryptophan virus protein
中文摘要
这项研究计划的长期目标是获得
关于蛋白质-核酸相互作用的详细信息
在分子水平上。 这些相互作用是基本的
细胞代谢的重要性,以及该领域的知识,
对健康领域有很大的益处,并促进其在健康领域的应用。
将使用三重态磁性的光学检测。
共振(ODMR)光谱,我们将主要研究
核酸结合蛋白的色氨酸残基。 相互作用
Trp残基和核酸之间的关系将使用
ODMR。 将利用外部重原子效应诱导
通过色氨酸残基和重原子之间的密切相互作用,
衍生的核酸。 此外,对兴奋的
Trp的状态是由与
将通过ODMR研究未衍生化的核酸碱基。 我们
建议研究蛋白质的复合,
优先于单链核酸(SSB蛋白),
多核苷酸和寡核苷酸。 一旦存在
与野生型SSB的芳族堆积相互作用已经被
建立,我们将研究突变蛋白质形成的复合物
以确定特定的色氨酸残基,
通过堆叠相互作用稳定复合物。 研究中心-
选择的寡核苷酸诱变将用于形成
突变株E. coli SSB和T4基因32蛋白,其基因具有
被我们的一个合作者克隆了 荧光和盐-
还将使用反滴定法评价以下因素的影响:
突变对核酸复合物的稳定性的影响。 我们将
使用类似于我们最近使用的策略,
鉴定E. coli SSB. 其他突变体
基因32蛋白,如琥珀突变体,将被研究,因为他们
都是可用的。 除了使用重原子衍生的核酸外,
酸,我们将开始采用聚(s2 U)作为衬底。 使用
三重态-三重态能量转移,我们可以产生
只有那些在附近的色氨酸的激发态
(and与)基地堆叠。 自旋排列守恒
将使我们能够获得结构数据,
Trp-碱基堆积复合物。 除了继续我们的工作
突变体E coli SSBs和T4基因32蛋白,我们还将
研究丝状噬菌体Pf 1的DNA结合蛋白。
我们现在将开始对真核SSB进行测量,例如
来自小牛胸腺的UP 1和UP 2,以及来自Rauscher的p10蛋白
鼠白血病病毒 后一种蛋白的初步工作是
完成.
英文摘要
The long-term objective of this research program is to acquire
detailed information regarding protein-nucleic acid interactions
at a molecular level. These interactions are of fundamental
importance in cellular metabolism, and knowledge in this area may
be of great benefit to, and foster applications in the health area.
Use will be made of optical detection of triplet state magnetic
resonance (ODMR) spectroscopy with which we will study mainly the
tryptophan residues of nucleic acid-binding proteins. Interactions
between Trp residues and nucleic acids will be evaluated using
ODMR. Use will be made of the external heavy atom effect induced
by close interactions between Trp residues and heavy atom-
derivatized nucleic acids. In addition, effects on the excited
states of Trp which result from stacking interactions with
underivatized nucleic acid bases will be investigated by ODMR. We
propose to study the complexing of proteins which bind
preferentially to single-stranded nucleic acids (SSB proteins) with
polynucleotides and oligonucleotides. Once the existence of
aromatic stacking interactions with wild type SSBs has been
established, we will study the complexes formed by mutant proteins
to identify specific Trp residues which are responsible for
stabilization of the complex through stacking interactions. Site-
selected oligonucleotide mutagenesis will be employed to form
mutants of E. coli SSB and of T4 gene 32 protein, whose genes have
been cloned by one of our collaborators. Fluorescence and salt-
back titrations will be used, as well, to evaluate the effects of
mutations on the stability of the nucleic acid complexes. We will
use a strategy similar to that which we have employed recently to
identify the stacked Trp residues in E. coli SSB. Other mutants
of gene 32 protein such as an amber mutant, will be studied as they
are available. In addition to using heavy atom-derivatized nucleic
acids, we will begin to employ poly (s2U) as a substrate. Using
triplet-triplet energy transfer from this substrate, we can produce
the excited states of only those Trp which are in the vicinity of
(and stacked with) the bases. Conservation of spin alignment
during energy transfer will enable us to obtain structural data on
the Trp-base stacked complex. In addition to continuing our work
on mutant E. coli SSBs and T4 gene 32 proteins, we also will
investigate the DNA binding protein_from the filamentous phage Pfl.
We will now begin to make measurements on eukaryotic SSBs, such as
UP1 and UP2 from calf thymus, and the p10 protein from Rauscher
murine leukemia virus. Preliminary work on the latter protein is
complete.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SPECTROSCOPY OF HEAVY ATOM-PERTURBED BIOPOLYMERS
-
批准号:2153171
-
项目类别:
-
资助金额:$12.21万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:6055890
-
项目类别:
-
资助金额:$16.99万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:3249973
-
项目类别:
-
资助金额:$11.4万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM-PERTURBED BIOPOLYMERS
-
批准号:2518618
-
项目类别:
-
资助金额:$13.72万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM-PERTURBED BIOPOLYMERS
-
批准号:2153173
-
项目类别:
-
资助金额:$13.21万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:3249967
-
项目类别:
-
资助金额:$12.87万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:3249972
-
项目类别:
-
资助金额:$8.48万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM-PERTURBED BIOPOLYMERS
-
批准号:2153172
-
项目类别:
-
资助金额:$12.72万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:3249975
-
项目类别:
-
资助金额:$12.06万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM-PERTURBED BIOPOLYMERS
-
批准号:3249970
-
项目类别:
-
资助金额:$12.52万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:6178258
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:3249971
-
项目类别:
-
资助金额:$8.47万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:3249969
-
项目类别:
-
资助金额:$11.53万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:3249974
-
项目类别:
-
资助金额:$11.77万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
SPECTROSCOPY OF HEAVY ATOM PERTURBED BIOPOLYMERS
-
批准号:2691410
-
项目类别:
-
资助金额:$16.55万
-
财政年份:1981
-
负责人:AUGUST H MAKI
-
依托单位:
DESIGN & DNA BINDING OF PEPTIDE INTERCALATORS: ANTIBIOTIC, ANTITUMOR DRUGS
-
批准号:3872110
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:AUGUST H MAKI
-
依托单位:
海外基金